Cargando…
Evaluating drug targets through human loss-of-function genetic variation
Naturally occurring human genetic variants that are predicted to inactivate protein-coding genes provide an in vivo model of human gene inactivation that complements knockout studies in cells and model organisms. Here we report three key findings regarding the assessment of candidate drug targets us...
Autores principales: | Minikel, Eric Vallabh, Karczewski, Konrad J., Martin, Hilary C., Cummings, Beryl B., Whiffin, Nicola, Rhodes, Daniel, Alföldi, Jessica, Trembath, Richard C., van Heel, David A., Daly, Mark J., Schreiber, Stuart L., MacArthur, Daniel G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272226/ https://www.ncbi.nlm.nih.gov/pubmed/32461653 http://dx.doi.org/10.1038/s41586-020-2267-z |
Ejemplares similares
-
Author Correction: Evaluating drug targets through human loss-of-function genetic variation
por: Minikel, Eric Vallabh, et al.
Publicado: (2021) -
Using high-resolution variant frequencies to empower clinical genome interpretation
por: Whiffin, Nicola, et al.
Publicado: (2017) -
Landscape of multi-nucleotide variants in 125,748 human exomes and 15,708 genomes
por: Wang, Qingbo, et al.
Publicado: (2020) -
Author Correction: Landscape of multi-nucleotide variants in 125,748 human exomes and 15,708 genomes
por: Wang, Qingbo, et al.
Publicado: (2021) -
The ExAC browser: displaying reference data information from over 60 000 exomes
por: Karczewski, Konrad J., et al.
Publicado: (2017)